LCN2 and obesity disorder: On the other hand, Xiaoli Chen’s group demonstrated that molecular disruption of LCN2 in mice significantly exacerbates diet-induced obesity, dyslipidemia, fatty liver disease, and insulin resistance (Guo et al., 2010).